Sg3 Management, LLC Allakos Inc. Put Options Transaction History

Sg3 Management, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 16, 2022	SELL	$5.08 - $9.81 $50,800 - $98,100	-10,000 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$8.55 - $111.89 $42,750 - $559,450	-5,000 Reduced 33.33%	10,000 $98,000
Q3 2021 Nov 15, 2021	SELL	$76.53 - $110.43 $1.15 Million - $1.66 Million	-15,000 Reduced 50.0%	15,000 $1.59 Million
Q1 2021 May 17, 2021	BUY	$109.73 - $153.66 $3.29 Million - $4.61 Million	30,000 New	30,000 $3.44 Million

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $22M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.